PL2142198T3 - Zmniejszenie ryzyka biegunki - Google Patents

Zmniejszenie ryzyka biegunki

Info

Publication number
PL2142198T3
PL2142198T3 PL08716958T PL08716958T PL2142198T3 PL 2142198 T3 PL2142198 T3 PL 2142198T3 PL 08716958 T PL08716958 T PL 08716958T PL 08716958 T PL08716958 T PL 08716958T PL 2142198 T3 PL2142198 T3 PL 2142198T3
Authority
PL
Poland
Prior art keywords
diarrhoea
risk
reduction
Prior art date
Application number
PL08716958T
Other languages
English (en)
Inventor
Florence Rochat
Karl-Josef Huber-Haag
Marie-Claire Fichot
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PL2142198T3 publication Critical patent/PL2142198T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL08716958T 2007-03-28 2008-02-20 Zmniejszenie ryzyka biegunki PL2142198T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07105078A EP1974735A1 (en) 2007-03-28 2007-03-28 Reduction of risk of diarrhoea
PCT/EP2008/052029 WO2008116708A1 (en) 2007-03-28 2008-02-20 Reduction of risk of diarrhoea
EP08716958.7A EP2142198B1 (en) 2007-03-28 2008-02-20 Reduction of risk of diarrhoea

Publications (1)

Publication Number Publication Date
PL2142198T3 true PL2142198T3 (pl) 2014-07-31

Family

ID=38314131

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08716958T PL2142198T3 (pl) 2007-03-28 2008-02-20 Zmniejszenie ryzyka biegunki

Country Status (17)

Country Link
US (1) US8562971B2 (pl)
EP (2) EP1974735A1 (pl)
CN (1) CN101641109A (pl)
AU (1) AU2008231930B2 (pl)
BR (1) BRPI0809630A2 (pl)
CA (1) CA2678525A1 (pl)
CL (1) CL2008000927A1 (pl)
ES (1) ES2454243T3 (pl)
MX (1) MX2009009670A (pl)
MY (1) MY150657A (pl)
PL (1) PL2142198T3 (pl)
PT (1) PT2142198E (pl)
RU (1) RU2491080C2 (pl)
TW (1) TW200911278A (pl)
UA (1) UA96984C2 (pl)
WO (1) WO2008116708A1 (pl)
ZA (1) ZA200907539B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007260074B2 (en) * 2006-06-13 2011-12-08 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains
EP2452574A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
US20110223137A1 (en) * 2008-12-05 2011-09-15 Nestec S.A. Compositions for use in low-birth weight infants
FI121952B (fi) * 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
TR201807143T4 (tr) * 2009-08-25 2018-06-21 Nestec Sa Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
EP2308498A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
JP2013543730A (ja) * 2010-11-11 2013-12-09 ネステク ソシエテ アノニム 非複製性プロバイオティクス微生物を含有するスプーナブルヨーグルト調製物
EP2452573A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
EP2452572A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for infants and children
CA2824960A1 (en) * 2011-02-04 2012-08-09 The Regents Of The University Of California Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
DK2734049T3 (en) 2011-06-20 2018-07-30 Heinz Co Brands H J Llc PROBIOTIC COMPOSITIONS AND PROCEDURES
US20140255365A1 (en) * 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof
US20150094266A1 (en) * 2013-06-11 2015-04-02 Novintethical Pharma, SA Xyloglucan and protein compositions for the treatment of intestinal disorders
ITMI20130960A1 (it) * 2013-06-11 2014-12-12 Novintethical Pharma Sagl Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
CA2945631C (en) * 2014-04-15 2023-04-11 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
RU2744271C2 (ru) * 2016-12-16 2021-03-04 Компани Жервэ Данон Пробиотическая композиция, содержащая штаммы Lactobacillus rhamnosus и Lactobacillus paracasei
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CN110432494A (zh) * 2018-05-03 2019-11-12 广州普维君健药业有限公司 防治婴幼儿过敏性湿疹和/或腹泻的益生菌组合物和应用
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
CA3238788A1 (en) 2021-11-22 2023-05-25 Eric Michael Schott Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DE69219768T2 (de) 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
JP4785315B2 (ja) 2000-01-21 2011-10-05 ユー.エス.ボラックス インコーポレイテッド ノナボレート組成物およびその製法
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
AU2006233918B2 (en) * 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress

Also Published As

Publication number Publication date
ES2454243T3 (es) 2014-04-10
CL2008000927A1 (es) 2009-03-27
ZA200907539B (en) 2011-04-28
PT2142198E (pt) 2014-04-02
MY150657A (en) 2014-02-14
EP1974735A1 (en) 2008-10-01
US20100129335A1 (en) 2010-05-27
RU2009139657A (ru) 2011-05-10
UA96984C2 (en) 2011-12-26
AU2008231930B2 (en) 2014-02-06
US8562971B2 (en) 2013-10-22
CN101641109A (zh) 2010-02-03
MX2009009670A (es) 2009-12-14
BRPI0809630A2 (pt) 2014-09-23
CA2678525A1 (en) 2008-10-02
WO2008116708A1 (en) 2008-10-02
TW200911278A (en) 2009-03-16
RU2491080C2 (ru) 2013-08-27
EP2142198A1 (en) 2010-01-13
EP2142198B1 (en) 2014-01-22
AU2008231930A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
ZA200907539B (en) Reduction of risk of diarrhoea
ZA201002568B (en) Herbicide-safener combination
PT2209856T (pt) Composições de aerogel.
GB0706633D0 (en) Combination
ZA201102604B (en) Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
ZA200906187B (en) Reducing side effects of tramadol
EP2286836A4 (en) IMMUNOSTIMULATING AGENT
PL2133419T3 (pl) Zastosowania beta-dipeptydów cyjanoficyny
GB0708379D0 (en) Area-partitioning
ZA201002562B (en) Combination thepary
HUE037214T2 (hu) Vasalás
GB0720292D0 (en) Equation solving
GB201114396D0 (en) Location of basesation
GB0709749D0 (en) Juglr
GB0707048D0 (en) Angle-match
GB0705589D0 (en) Parkapatch
GB0806623D0 (en) My leener
AU3613P (en) LS005A01 Leucospermum cuneiforme
GB0705204D0 (en) Uses of (S)-clenbuterol
PL383758A1 (pl) Nowe zastosowanie undekan-2-onu
PL383759A1 (pl) Nowe zastosowanie undekan-2-olu
PL383760A1 (pl) Nowe zastosowanie undekan-2-olu
PL385196A1 (pl) Kształtownik
HU0700365D0 (en) Combination
GB0707145D0 (en) Combination therapy - 793